CRT 2025

Coronary

Cardiogenic Shock

The Absence of Evidence is Not Evidence of Absence: The Role of Drug and Device-Based Therapies in Cardiogenic Shock in 2025

Speaker(s)

• 

  Shashank S. Sinha, MD, MSc

  Director, Cardiac ICU; Director, Cardiovascular Critical Care Research
  Inova Schar Heart and Vascular / Inova Fairfax Medical Campus
  Fairfax, Virginia, United States

  Disclosure(s): No financial relationships to disclose